165 related articles for article (PubMed ID: 11783618)
1. The effects of PTH (1-34) on bone structure and strength in ovariectomized monkeys.
Turner CH; Burr DB; Hock JM; Brommage R; Sato M
Adv Exp Med Biol; 2001; 496():165-79. PubMed ID: 11783618
[No Abstract] [Full Text] [Related]
2. Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis).
Jerome CP; Johnson CS; Vafai HT; Kaplan KC; Bailey J; Capwell B; Fraser F; Hansen L; Ramsay H; Shadoan M; Lees CJ; Thomsen JS; Mosekilde L
Bone; 1999 Sep; 25(3):301-9. PubMed ID: 10495134
[TBL] [Abstract][Full Text] [Related]
3. [Parathyroid and bone. Effect of parathyroid hormone on bone quality].
Ito M
Clin Calcium; 2007 Dec; 17(12):1858-64. PubMed ID: 18057661
[TBL] [Abstract][Full Text] [Related]
4. Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits.
Hirano T; Burr DB; Turner CH; Sato M; Cain RL; Hock JM
J Bone Miner Res; 1999 Apr; 14(4):536-45. PubMed ID: 10234574
[TBL] [Abstract][Full Text] [Related]
5. Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys.
Fox J; Miller MA; Newman MK; Recker RR; Turner CH; Smith SY
Bone; 2007 Sep; 41(3):321-30. PubMed ID: 17573250
[TBL] [Abstract][Full Text] [Related]
6. Effects of 16-month treatment with the cathepsin K inhibitor ONO-5334 on bone markers, mineral density, strength and histomorphometry in ovariectomized cynomolgus monkeys.
Yamada H; Ochi Y; Mori H; Nishikawa S; Hashimoto Y; Nakanishi Y; Tanaka M; Bruce M; Deacon S; Kawabata K
Bone; 2016 May; 86():43-52. PubMed ID: 26921823
[TBL] [Abstract][Full Text] [Related]
7. Sequential Treatment with Eldecalcitol After PTH Improves Bone Mechanical Properties of Lumbar Spine and Femur in Aged Ovariectomized Rats.
Sakai S; Hongo H; Yamamoto T; Hasegawa T; Takeda S; Saito H; Endo K; Yogo K; Amizuka N
Calcif Tissue Int; 2019 Mar; 104(3):251-261. PubMed ID: 30467731
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral and collagen quality in humeri of ovariectomized cynomolgus monkeys given rhPTH(1-34) for 18 months.
Paschalis EP; Burr DB; Mendelsohn R; Hock JM; Boskey AL
J Bone Miner Res; 2003 Apr; 18(4):769-75. PubMed ID: 12674338
[TBL] [Abstract][Full Text] [Related]
9. Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys.
Brommage R; Hotchkiss CE; Lees CJ; Stancill MW; Hock JM; Jerome CP
J Clin Endocrinol Metab; 1999 Oct; 84(10):3757-63. PubMed ID: 10523026
[TBL] [Abstract][Full Text] [Related]
10. ZP2307, a novel, cyclic PTH(1-17) analog that augments bone mass in ovariectomized rats.
Neerup TS; Stahlhut M; Petersen JS; Daugaard JR; Jensen JE; Peng Z; Morko J; Thorkildsen C
Bone; 2011 Jun; 48(6):1319-27. PubMed ID: 21376152
[TBL] [Abstract][Full Text] [Related]
11. Skeletal effects of parathyroid hormone (1-34) in ovariectomized rats with or without concurrent administration of salmon calcitonin.
DeLuca PP; Dani BA
AAPS PharmSci; 2001; 3(4):E27. PubMed ID: 12049490
[TBL] [Abstract][Full Text] [Related]
12. Accretion of bone mass and strength with parathyroid hormone prior to the onset of estrogen deficiency can provide temporary beneficial effects in skeletally mature rats.
Shen V; Birchman R; Liang XG; Wu DD; Dempster DW; Lindsay R
J Bone Miner Res; 1998 May; 13(5):883-90. PubMed ID: 9610753
[TBL] [Abstract][Full Text] [Related]
13. The positive effect of parathyroid hormone on femoral neck bone strength in ovariectomized rats is more pronounced than that of estrogen or bisphosphonates.
Søgaard CH; Wronski TJ; McOsker JE; Mosekilde L
Endocrinology; 1994 Feb; 134(2):650-7. PubMed ID: 8299562
[TBL] [Abstract][Full Text] [Related]
14. Effects of long term treatment with high doses of odanacatib on bone mass, bone strength, and remodeling/modeling in newly ovariectomized monkeys.
Duong LT; Pickarski M; Cusick T; Chen CM; Zhuo Y; Scott K; Samadfam R; Smith SY; Pennypacker BL
Bone; 2016 Jul; 88():113-124. PubMed ID: 27126999
[TBL] [Abstract][Full Text] [Related]
15. Effects of treatment with parathyroid hormone 1-84 on quantity and biomechanical properties of thoracic vertebral trabecular bone in ovariectomized rhesus monkeys.
Fox J; Newman MK; Turner CH; Guldberg RE; Varela A; Smith SY
Calcif Tissue Int; 2008 Mar; 82(3):212-20. PubMed ID: 18297227
[TBL] [Abstract][Full Text] [Related]
16. Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT.
Hansen S; Hauge EM; Beck Jensen JE; Brixen K
J Bone Miner Res; 2013 Apr; 28(4):736-45. PubMed ID: 23044908
[TBL] [Abstract][Full Text] [Related]
17. Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats.
Sato M; Zeng GQ; Turner CH
Endocrinology; 1997 Oct; 138(10):4330-7. PubMed ID: 9322947
[TBL] [Abstract][Full Text] [Related]
18. Intermittent Ibandronate Maintains Bone Mass, Bone Structure, and Biomechanical Strength of Trabecular and Cortical Bone After Discontinuation of Parathyroid Hormone Treatment in Ovariectomized Rats.
Takeda S; Sakai S; Tanaka K; Tomizawa H; Serizawa K; Yogo K; Urayama K; Hashimoto J; Endo K; Matsumoto Y
Calcif Tissue Int; 2017 Jul; 101(1):65-74. PubMed ID: 28246925
[TBL] [Abstract][Full Text] [Related]
19. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM
J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
[TBL] [Abstract][Full Text] [Related]
20. The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats.
Mosekilde L; Danielsen CC; Gasser J
Endocrinology; 1994 May; 134(5):2126-34. PubMed ID: 8156913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
